AYAH SULEIMAN: Open Payments
NPI 1679335582 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 33 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $207 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $141 |
| GlaxoSmithKline, LLC. | 2 | $137 |
| Lilly USA, LLC | 7 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Corcept Therapeutics | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: SHINGRIX, Wegovy, MOUNJARO, Kerendia, JARDIANCE, Ozempic, Korlym, ZEPBOUND.
Industry payments across NJ — which companies pay providers there.
